Zhuhai Rundu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is OLMESARTAN MEDOXOMIL, with a corresponding US DMF Number 34941.
Remarkably, this DMF maintains an Active status since its submission on December 23, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 16, 2021, and payment made on August 05, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II